The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech; Janssen; Lilly; Merck
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech; Lilly; Merck
 
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; Pfizer; Roche
Randomized, open-label phase Ib/II study of atezolizumab with or without daratumumab in previously treated advanced or metastatic non-small cell lung cancer (NSCLC).
 
Rathi Narayana Pillai
Consulting or Advisory Role - Natera
Travel, Accommodations, Expenses - Clovis Oncology; Genentech/Roche; Novartis; Takeda
 
Suresh S. Ramalingam
No Relationships to Disclose
 
David P. Carbone
Honoraria - ARIAD; AstraZeneca; Bayer; Biocept; Biothera; Boehringer Ingelheim; Bristol-Myers Squibb; Cancer Support Community; Clovis Oncology; Genentech/Roche; Guardant Health; Inivata; Janssen Diagnostics; Merck; Novartis
Consulting or Advisory Role - ARIAD; AstraZeneca; Bayer; Biocept; Biothera; Boehringer Ingelheim; Bristol-Myers Squibb; Cancer Support Community; Clovis Oncology; Genentech/Roche; Guardant Health; Inivata; Janssen Diagnostics; Merck; Novartis
Research Funding - Bristol-Myers Squibb
 
Luis G. Paz-Ares
No Relationships to Disclose
 
Meena Thayu
Employment - Janssen Research & Development
 
Patricia Watson
Employment - Janssen Research & Development
 
Nushmia Z. Khokhar
Employment - Janssen Research & Development
 
Martin Reck
No Relationships to Disclose